BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12943944)

  • 41. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant.
    Jobe PC; Browning RA
    Epilepsy Behav; 2005 Dec; 7(4):602-19. PubMed ID: 16169281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular effects of tricyclic antidepressants in childhood asthma: a case series and review.
    Wamboldt MZ; Yancey AG; Roesler TA
    J Child Adolesc Psychopharmacol; 1997; 7(1):45-64. PubMed ID: 9192541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?
    Buysse DJ; Reynolds CF; Houck PR; Perel JM; Frank E; Begley AE; Mazumdar S; Kupfer DJ
    J Clin Psychiatry; 1997 Oct; 58(10):426-32. PubMed ID: 9375592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].
    Ontiveros-Sánchez de la Barquera JA
    Gac Med Mex; 2017; 153(6):688-694. PubMed ID: 29206826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New developments in the treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of response to amine-specific antidepressants.
    Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
    J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.
    Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS
    Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine.
    Stager SV; Ludlow CL; Gordon CT; Cotelingam M; Rapoport JL
    J Speech Hear Res; 1995 Jun; 38(3):516-25. PubMed ID: 7674643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
    Fiedorowicz JG; Takezawa K; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Course and rate of antidepressant response in the very old.
    Gildengers AG; Houck PR; Mulsant BH; Pollock BG; Mazumdar S; Miller MD; Dew MA; Frank E; Kupfer DJ; Reynolds CF
    J Affect Disord; 2002 May; 69(1-3):177-84. PubMed ID: 12103464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
    Rudolph RL; Feiger AD
    J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
    Leonard HL; Meyer MC; Swedo SE; Richter D; Hamburger SD; Allen AJ; Rapoport JL; Tucker E
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
    Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
    Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
    Jorge RE; Robinson RG; Arndt S; Starkstein S
    Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of antidepressants on the course of disability following stroke.
    Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.